These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 3741715

  • 1. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
    Bach D, Blevins R, Kerner N, Rubenfire M, Edwards DJ.
    Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
    [Abstract] [Full Text] [Related]

  • 2. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH, Back DJ, Breckenridge AM, Howells RE.
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [Abstract] [Full Text] [Related]

  • 3. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
    Abernethy DR, Egan JM, Dickinson TH, Carrum G.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
    [Abstract] [Full Text] [Related]

  • 4. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
    Anadón A, Martinez-Larrañaga MR, Fernandez MC, Diaz MJ, Bringas P.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
    [Abstract] [Full Text] [Related]

  • 5. The effect of age and sex on metabolism and urinary excretion of antipyrine.
    Jorquera F, Almar M, Pozuelo M, Sansegundo D, González-Sastre M, González-Gallego J.
    J Gerontol A Biol Sci Med Sci; 1998 Jan; 53(1):M14-9. PubMed ID: 9467428
    [Abstract] [Full Text] [Related]

  • 6. Effect of deltamethrin on antipyrine pharmacokinetics and metabolism in rat.
    Anadón A, Martinez-Larrañaga MR, Díaz MJ, Bringas P, Fernandez MC.
    Arch Toxicol; 1991 Jan; 65(2):156-9. PubMed ID: 2059156
    [Abstract] [Full Text] [Related]

  • 7. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M.
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [Abstract] [Full Text] [Related]

  • 8. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
    Bottorff MB, Lalonde RL, Kazierad DJ, Hoon TJ, Tsiu SJ, Mirvis DM.
    Pharmacotherapy; 1989 Jun; 9(5):315-21. PubMed ID: 2510135
    [Abstract] [Full Text] [Related]

  • 9. Effect of chloroquine and primaquine on antipyrine metabolism.
    Back DJ, Purba HS, Park BK, Ward SA, Orme ML.
    Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
    [Abstract] [Full Text] [Related]

  • 10. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
    Teunissen MW, Kampf D, Roots I, Vermeulen NP, Breimer DD.
    Eur J Clin Pharmacol; 1985 Nov; 28(5):589-95. PubMed ID: 4043202
    [Abstract] [Full Text] [Related]

  • 11. The effect of oral verapamil therapy on antipyrine clearance.
    Rumiantsev DO, Piotrovskii VK, Riabokon OS, Slastnikova ID, Kokurina EV, Metelitsa VI.
    Br J Clin Pharmacol; 1986 Nov; 22(5):606-9. PubMed ID: 3790408
    [Abstract] [Full Text] [Related]

  • 12. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM, Teunissen MW, Breimer DD.
    Drug Metab Dispos; 1981 Nov; 9(6):541-4. PubMed ID: 6120813
    [Abstract] [Full Text] [Related]

  • 13. Effect of age on the pharmacokinetics of antipyrine in calves.
    Janus K, Suszycka J.
    Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of enzyme induction on antipyrine metabolite formation.
    Danhof M, Verbeek RM, van Boxtel CJ, Boeijinga JK, Breimer DD.
    Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
    [Abstract] [Full Text] [Related]

  • 15. Antipyrine clearance and metabolism in patients with psoriasis.
    Kubota K, Ishizaki T, Chiba K, Takagi A, Nakagawa A, Nakamura K.
    Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
    [Abstract] [Full Text] [Related]

  • 16. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
    Ohashi K, Sakamoto K, Sudo T, Tateishi T, Harada K, Fujimura A, Ebihara A, Tanaka E.
    J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
    [Abstract] [Full Text] [Related]

  • 17. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians.
    Ali HA, el-Yazigi A, Sieck JO, Døssing M, Saour J, Raines DA, Ernst P.
    Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682
    [Abstract] [Full Text] [Related]

  • 18. Effect of experimental fasciolosis on antipyrine metabolism and clearance in water buffaloes.
    Jiang SX, Bayón JE, Ferre I, Mao XZ, González-Gallego J.
    Vet Parasitol; 2000 Mar 01; 88(3-4):177-86. PubMed ID: 10714456
    [Abstract] [Full Text] [Related]

  • 19. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M, van Zuilen A, Boeijinga JK, Breimer DD.
    Eur J Clin Pharmacol; 1982 Mar 01; 21(5):433-41. PubMed ID: 7075648
    [Abstract] [Full Text] [Related]

  • 20. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
    Teunissen MW, Joeres RP, Vermeulen NP, Breimer DD.
    Xenobiotica; 1983 Apr 01; 13(4):223-31. PubMed ID: 6624137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.